Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Effect of Nano-Curcumin Supplementation on Pentraxin 3 Gene Expression and Serum Level in Migraine Patients Publisher



Djalali M1 ; Djalali M1 ; Abdolahi M2 ; Mohammadi H3 ; Heidari H3 ; Hosseini S4 ; Sadeghizadeh M1
Authors

Source: Reports of Biochemistry and Molecular Biology Published:2020


Abstract

Background: This study was designed to investigate the effect of nano-curcumin supplementation on pentraxin 3 (PTX3) gene expression and serum level in migraine patients. Methods: The present study, performed as a clinical trial, included 38 episodic migraine patients in two groups that received either nano-curcumin or placebo over a two-month period. At the start and the end of the study, PTX3 gene expression and serum levels were measured. Results: After two months of treatment, PTX3 gene expression and serum levels were both significantly less in the nano-curcumin than in the placebo group (P= 0.01 and P< 0.001, respectively). No significant gene expression differences were found between the two groups. Conclusions: Curcumin may have a potential inhibitory effect on PTX3 gene expression and serum levels in migraine disease and can be considered as an efficient therapy in migraine management. © 2020. Reports of Biochemistry and Molecular Biology.All Rights Reserved
Other Related Docs
11. Dietary Supplementation in Migraine: A Focus on Omega-3 Fatty Acids, Treatments# Nutraceuticals# Supplements# and Herbal Medicine in Neurological Disorders (2023)
18. Molecular Mechanisms of Curcumin in Neuroinflammatory Disorders: A Mini Review of Current Evidences, Endocrine# Metabolic and Immune Disorders - Drug Targets (2019)
19. Evaluation of Inflammatory State in Migraineurs: A Case-Control Study, Iranian Journal of Allergy# Asthma and Immunology (2020)